Get notified when TPST files again. Create a free account and we'll email you the moment its next filing is analyzed.

Get filing alerts
NASDAQ: TPST Tempest Therapeutics, Inc. 8-K

Tempest secures up to $50M equity line with Lincoln Park, issues 560K commitment-fee shares

Filed August 13, 2026 · Period ending August 13, 2026 · ~2 min read

Key Changes

  • high

    Tempest entered a up to $50M equity line of credit with Lincoln Park Capital, allowing the company to sell common stock at its discretion over 24 months. The facility starts at $25M, expanding to up to $50M after the initial tranche is utilized.

    Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
  • high

    Nasdaq rules cap issuances at 19.99% of pre-agreement outstanding shares unless shareholders approve more or the average sale price meets or exceeds $1.3854 per share, limiting near-term dilution unless the stock price holds above that floor.

    Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →
  • medium

    The company issued 560,356 shares immediately as a commitment fee, with an additional 350,223 shares due after the first $25M is drawn. These shares represent upfront dilution separate from any future sales under the facility.

    Item 1.01 — Entry into a Material Definitive Agreement verify on EDGAR →

2 more material changes behind this preview — plus the full narrative summary, section-by-section diffs against the prior filing, and verbatim quotes with EDGAR citations.

Read 3 full reports/month free No card required. Takes 30 seconds.

Want to see a complete report first? Today's free report (VG 10-Q) is open in full — no account needed.

Partner

Trade TPST commission-free

Open an account, get a free stock.

Sign up

Investing involves risk. Free stock terms apply.

Was this report useful?

Figures/quotes linked to EDGAR · Narrative written by AI · Aug 13, 2026 · How we verify